BLASUBCUTANEOUSINJECTABLE4 Generics Approved
Approved
Jun 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
NOVOLOG PENFILL (water injection) by Novo Nordisk. Approved for insulin analog [epc]. First approved in 2000.
Drug data last refreshed 18h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NOVOLOG PENFILL is a rapid-acting insulin analog administered via subcutaneous injection in a prefilled pen delivery system. It is indicated for the treatment of diabetes mellitus to improve glycemic control in patients requiring insulin therapy. The product works by mimicking the body's natural insulin response, facilitating glucose uptake and metabolism. As a rapid-acting insulin, NOVOLOG PENFILL is typically used at meal times and represents a key component of insulin regimens for both Type 1 and Type 2 diabetes management.
$0.0BPart D
Mechanism of Action
Pharmacologic Class:
Insulin Analog
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Investigation of the Analgesic Effects of Intradermal and Subdermal Sterile Water Injection on Active Labor Pain
Started Jan 2024
Career Relevance
NOVOLOG PENFILL supports commercial roles including brand managers, sales representatives, and medical science liaisons focused on endocrinology and primary care. Key competencies include deep knowledge of insulin pharmacokinetics, insulin delivery device mechanics, formulary management, and competitive positioning against basal-bolus alternatives. Currently zero open positions are linked to this product in the database, reflecting its mature and declining market position.
Company
Worked on NOVOLOG PENFILL at Novo Nordisk? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.